Independent
Yoshihiro Oyamada
4/5/2019
Private
January 29, 2019
SMBC Venture Capital, Nippon Venture Capital, Dainippon Sumitomo Pharma, Kyoto University Innovation Capital, Shinsei Capital Partners
NA